
- Telehealth Visits
- Insurance plan information

Yvonne G. Lin-Liu, MD, MS
Gynecologic Oncology • Gynecologic Surgical Oncology- Telehealth Visits
- Insurance plan information



Yvonne G. Lin-Liu, MD, MS
Gynecologic Oncology • Gynecologic Surgical Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Yvonne G. Lin-Liu specializes in treating gynecologic cancers. She believes that knowledge is power, so she strives to help her patients understand the biology of their disease and all of their treatment options. Much of her practice focuses on serving women seeking second opinions and helping them make the best treatment decisions.
After earning a bachelor's degree in chemistry from the Massachusetts Institute of Technology, Lin-Liu completed a master of science degree in epidemiology at the Harvard T.H. Chan School of Public Health and then received a Fulbright fellowship to Taiwan. She earned her medical degree from the University of California, Irvine. She completed a residency in obstetrics and gynecology at Beth Israel Deaconess Medical Center and a fellowship in gynecologic oncology at the University of Texas MD Anderson Cancer Center.
Previously, Lin-Liu was a physician-scientist studying the impact of obesity on cellular stress, inflammation and endometrial cancer development. She joined Genentech in 2014 to advance the development of new cancer therapies for women around the world. Currently a medical director at Genentech in South San Francisco, she strongly believes that continuing to care for patients as a physician is key to improving treatment options for women with gynecologic cancers.
Lin-Liu has presented her research at multiple meetings and has published in prominent journals, including Cancer, the New England Journal of Medicine, Journal of the National Cancer Institute, Clinical Cancer Research and Oncogene. She is an active member of the Society of Gynecologic Oncology, Western Association of Gynecologic Oncologists, American Association for Cancer Research and American Society of Clinical Oncology. She volunteers on various society committees focused on professional development.
Education & training
Board certification
- Gynecologic Oncology, American Board of OB/Gynecologic Oncology
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Fellowship
- Gynecologic Oncology, Univ of Texas MD Anderson Cancer Center
Residency
- Obstetrics & Gynecology, Beth Israel Deaconess Medical Center GME
Internship
- Obstetrics & Gynecology, Beth Israel Deaconess Medical Center GME
Degree
- MD, University of California Irvine College of Medicine
My expertise
Specialties
- Gynecologic Oncology
- Gynecologic Surgical Oncology
- Gynecologic Medical Oncology
Conditions
- Gynecologic Cancer
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%222577%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222577%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 24 reviews
- November 26, 20255 out of 5 Stars
Dr. Lin Liu is the BEST
- October 6, 20255 out of 5 Stars
I am so lucky to be under her care. Her team is also excellent.
- September 29, 20255 out of 5 Stars
I am grateful to Yvonne Lin Liu for her clear and concise communication and obvious care for me.
- September 26, 20255 out of 5 Stars
All my questions were answered to my satisfaction and a test was arranged as a precaution.
- September 26, 20255 out of 5 Stars
She was so helpful I had no problems
- August 5, 20255 out of 5 Stars
Dr. Lin-Liu always went above and beyond in making sure I understood my treatment and gave me agency in all decisions.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.